iRhythm Holdings (IRTC) Interest Coverage Ratio Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -40.19% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -12.04% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 8.92% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -54.61% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -6.18% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 66.99% |
| 10 | iRhythm Holdings | 3.55 Bn | 3.00 Bn | 141.35 Mn | 50.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.54% |
| Dec 31, 2025 | 155.95% |
| Sep 30, 2025 | 83.00% |
| Jun 30, 2025 | 17.75% |
| Mar 31, 2025 | 25.41% |
| Dec 31, 2024 | 97.05% |
| Sep 30, 2024 | 49.25% |
| Jun 30, 2024 | 69.41% |
| Mar 31, 2024 | 67.93% |
| Dec 31, 2023 | -103.79% |
| Sep 30, 2023 | 13.29% |
| Jun 30, 2023 | 53.38% |
| Mar 31, 2023 | -73.79% |
| Dec 31, 2022 | 84.26% |
| Sep 30, 2022 | 58.85% |
| Jun 30, 2022 | 12.10% |
| Mar 31, 2022 | 70.82% |
| Dec 31, 2021 | -406.82% |
| Sep 30, 2021 | -573.62% |
| Jun 30, 2021 | -4.59% |
| Mar 31, 2021 | -239.69% |
| Dec 31, 2020 | 44.36% |
| Sep 30, 2020 | 72.25% |
| Jun 30, 2020 | -120.39% |
| Mar 31, 2020 | -20.34% |
| Dec 31, 2019 | -88.16% |
| Sep 30, 2019 | -316.87% |
| Jun 30, 2019 | -61.75% |
| Mar 31, 2019 | -62.39% |
| Dec 31, 2018 | -93.21% |
| Sep 30, 2018 | -54.30% |
| Jun 30, 2018 | -110.34% |
| Mar 31, 2018 | -113.98% |
| Dec 31, 2017 | -150.49% |
| Sep 30, 2017 | -110.10% |
| Jun 30, 2017 | -53.28% |
| Mar 31, 2017 | 5.79% |
| Dec 31, 2016 | 57.32% |
| Sep 30, 2016 | 86.67% |